Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
Dupixent COPD delay possible, Eylea down 2%, Regeneron says
The FDA has requested more efficacy data for Sanofi and Regeneron's Dupixent in COPD. Additionally, Eylea sales fell by 2% in the first quarter.
Kevin Dunleavy
May 2, 2024 12:00pm
Moderna plots launch of its next potential mRNA vaccine approval
May 2, 2024 11:08am
Emergent to cut 300 jobs, shutter 2 facilities in major overhaul
May 1, 2024 5:06pm
Lilly: Zepbound, Mounjaro supply to remain tight through 2024
Apr 30, 2024 12:03pm
WuXi AppTec stays the course amid US biosecurity crackdown
Apr 30, 2024 9:30am
Samsung Biologics achieves record Q1 earnings
Apr 30, 2024 9:09am